Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4251
PUT
Tapestry
TPR
$31.5B
| $1.42M | ﹤0.01% |
38,300
-43,800
| -53% | -$1.8M |
|
4252
Vanguard Morningstar Value ETF
VTV
$191B
| $1.42M | ﹤0.01% |
+10,471
| New | +$1.46M |
|
|
PUCK
4253
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
| $1.42M | ﹤0.01% |
145,818
+108,876
| +295% | +$1.05M |
|
|
CONE
4254
CALL
DELISTED
CyrusOne Inc Common Stock
CONE
| $1.42M | ﹤0.01% |
+18,300
| New | +$1.38M |
|
4255
Treace Medical Concepts
TMCI
$309M
| $1.41M | ﹤0.01% |
52,575
+42,788
| +437% | +$1.18M |
|
4256
X4 Pharmaceuticals
XFOR
$405M
| $1.41M | ﹤0.01% |
8,912
-3,955
| -31% | -$651K |
|
|
SYRS
4257
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.41M | ﹤0.01% |
31,638
-24,133
| -43% | -$1.18M |
|
4258
Hanover Insurance
THG
$7.94B
| $1.41M | ﹤0.01% |
10,903
-61,262
| -85% | -$8.34M |
|
4259
Aquestive Therapeutics
AQST
$468M
| $1.41M | ﹤0.01% |
323,774
-114,080
| -26% | -$447K |
|
4260
CALL
QuidelOrtho
QDEL
$1.2B
| $1.41M | ﹤0.01% |
+10,000
| New | +$1.34M |
|
4261
CALL
Fortive
FTV
$18.3B
| $1.41M | ﹤0.01% |
26,540
+13,270
| +100% | +$726K |
|
4262
Insulet
PODD
$11.5B
| $1.41M | ﹤0.01% |
4,957
-113,941
| -96% | -$32.5M |
|
4263
PUT
Cardinal Health
CAH
$54.6B
| $1.41M | ﹤0.01% |
+28,400
| New | +$1.54M |
|
|
MILE
4264
DELISTED
Metromile, Inc. Common Stock
MILE
| $1.4M | ﹤0.01% |
395,539
+145,539
| +58% | +$821K |
|
4265
NextDecade
NEXT
$1.75B
| $1.4M | ﹤0.01% |
504,580
-404,771
| -45% | -$1.28M |
|
4266
Forestar Group
FOR
$1.5B
| $1.4M | ﹤0.01% |
75,232
+11,765
| +19% | +$238K |
|
|
RTLR
4267
DELISTED
Rattler Midstream LP Common Units
RTLR
| $1.4M | ﹤0.01% |
119,448
-7,810
| -6% | -$84.6K |
|
4268
Alliant Energy
LNT
$18.3B
| $1.4M | ﹤0.01% |
25,022
-13,250
| -35% | -$783K |
|
4269
Vanguard Energy ETF
VDE
$9.91B
| $1.4M | ﹤0.01% |
18,957
+15,141
| +397% | +$1.06M |
|
4270
Genasys
GNSS
$79.7M
| $1.4M | ﹤0.01% |
270,252
-375,560
| -58% | -$2.02M |
|
|
SLAMU
4271
DELISTED
Slam Corp. Unit
SLAMU
| $1.4M | ﹤0.01% |
141,000
-827,311
| -85% | -$8.25M |
|
4272
Stoke Therapeutics
STOK
$1.99B
| $1.4M | ﹤0.01% |
+54,825
| New | +$1.53M |
|
4273
CALL
Willis Towers Watson
WTW
$31.6B
| $1.4M | ﹤0.01% |
6,000
-29,600
| -83% | -$6.59M |
|
4274
Banzai International
BNZI
$6.36M
| $1.39M | ﹤0.01% |
14
+8
| +133% | +$776K |
|
|
ADN
4275
DELISTED
Advent Technologies
ADN
| $1.39M | ﹤0.01% |
+5,334
| New | +$1.3M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.